Correction to Dr S. O. Onal’s Affiliation in a Clinical Digital Health Study
-
October 16, 2026
October 16, 2026
Four deaths among evenamide-treated patients prompted FDA concerns about possible fatal arrhythmias, although a causal link remains unconfirmed.
by Mouj Hijazi
October 8, 2026
by Hassan Jubair, Md Abu Kawsar Prodhan Hemal, Fariah Tabbasum
October 15, 2026
All 3 monthly doses improved schizophrenia symptoms versus placebo in the phase 3 SOLARIS trial.
by Mouj Hijazi
October 9, 2026